Prognosis of patients with newly diagnosed glioblastoma treated with molecularly targeted drugs combined with radiotherapy vs temozolomide monotherapy-Reference-Cited by-同舟云学术

Prognosis of patients with newly diagnosed glioblastoma treated with molecularly targeted drugs combined with radiotherapy vs temozolomide monotherapy

Published:2019-11 Issue:45 Volume:98 Page:e17759
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Wang Wen-Lei,Aru Na,Liu Zhi,Shen Xun,Ding Yi-Ming,Wu Shi-Ju,Qin Huai-Hai,Jin Wen-Yi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference38 articles.

1. Improvement in treatment results of glioblastoma over the last three decades and beneficial factors;Kawano;Br J Neurosurg,2015

2. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol,2009

3. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

4. Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial;Gilbert;J Clin Oncol,2013

5. Novel anti-angiogenic therapies for malignant gliomas;Norden;Lancet Neurol,2008

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Efficacy of Laser Interstitial Thermal Therapy as Upfront Therapy in Primary Glioblastoma and IDH-Mutant Astrocytoma: A Meta-Analysis;Cancers;2024-06-03

2. Targeted therapies in patients with newly diagnosed glioblastoma—A systematic meta‐analysis of randomized clinical trials;International Journal of Cancer;2023-01-30

3. Glioblastoma and the search for non-hypothesis driven combination therapeutics in academia;Frontiers in Oncology;2023-01-17

4. Methylation associated miR-1246 contributes to poor prognosis in gliomas treated with temozolomide;Clinical Neurology and Neurosurgery;2021-01

5. The efficacy and safety of radiotherapy with adjuvant temozolomide for glioblastoma: A meta-analysis of randomized controlled studies;Clinical Neurology and Neurosurgery;2020-09